Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026)
Quanterix's (QTRX) quarterly Total Non-Current Liabilities came in at $81.0 million in Q1 2026, up 5.98% YoY from $76.4 million in Q1 2025, and down 29.54% on a QoQ basis from $114.9 million in Q4 2025.
Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Total Non-Current Liabilities data on file, last reported at $81.0 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 5.98% year-over-year to $81.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.0 million (up 5.98% YoY) and the FY2025 annual result came in at $114.9 million, up 50.26% from the prior year.
- Total Non-Current Liabilities slipped to $81.0 million in Q1 2026, from $114.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $122.3 million in Q3 2025 to a low of $69.3 million in Q1 2023.
- A 5-year average of $80.5 million and a median of $76.4 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities retreated 9.96% — and 2025, when it jumped 71.81%.
- Tracing QTRX's Total Non-Current Liabilities over 5 years: stood at $74.2 million in 2022, then climbed by 4.38% to $77.4 million in 2023, then retreated by 1.21% to $76.5 million in 2024, then surged by 50.26% to $114.9 million in 2025, then declined by 29.54% to $81.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $81.0 million (Q1 2026), $114.9 million (Q4 2025), and $122.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Quanterix | 146.22 Mn | 52.69 Mn | 12.67 Mn | 78.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.59 Mn |
| Mar 31, 2026 | 80.99 Mn |
| Dec 31, 2025 | 114.94 Mn |
| Sep 30, 2025 | 122.31 Mn |
| Jun 30, 2025 | 82.36 Mn |
| Mar 31, 2025 | 76.42 Mn |
| Dec 31, 2024 | 76.50 Mn |
| Sep 30, 2024 | 71.19 Mn |
| Jun 30, 2024 | 74.12 Mn |
| Mar 31, 2024 | 69.77 Mn |
| Dec 31, 2023 | 77.43 Mn |
| Sep 30, 2023 | 75.33 Mn |
| Jun 30, 2023 | 73.29 Mn |
| Mar 31, 2023 | 69.31 Mn |
| Dec 31, 2022 | 74.18 Mn |
| Sep 30, 2022 | 72.71 Mn |
| Jun 30, 2022 | 81.40 Mn |
| Mar 31, 2022 | 76.54 Mn |
| Dec 31, 2021 | 58.54 Mn |
| Mar 31, 2021 | 58.82 Mn |